One More Brick On The Back Of Drowning National Health Care System

Published Jun 30, 2014
Taichung, Taiwan - Patients with diabetes mellitus (DM) have created 4.3 times more medical expenditures, accounting for 11.5% of the Taiwanese total health care cost, in 2001. While patients with respiratory failure (RF) requiring mechanical ventilation (MV) are associated with significant economic burden (US$22,530 per year), DM was found to be the leading cause of further complications for patients with respiratory failure. Due to the increased requirement of MV and prolonged hospitalization among such a high-risk population, more effective strategies to better manage DM patients are warranted in response to the growing burdens on health care providers and the social  health system worldwide. Researchers from China Medical University in Taiwan examined the impacts of comorbid diabetes mellitus on medical expenditures among patients with respiratory failure requiring medical ventilation under the implementation of single-payer national health care in Taiwan. Under the National Health Insurance (NHI) in Taiwan, diabetic patients who are mechanically ventilated due to respiratory failure are more commonly male patients with more severe organ dysfunction.  Such patients consumed significantly more health care resources, with the greatest medical expenditure occurring at the ages of 18-29 years during 2004-2010. One third of respiratory failure patients were diabetic, while more than three quarters of them were aged 60 years or above. These diabetic RF patients consumed more hospital medical expenditure for respiratory failure care (additional $1,119 versus $1,469) than those non-diabetic RF patients, regardless of discharge status. “Diabetes is a comorbidity that significantly affects disease status and increases medical expenditures among mechanically ventilated patients due to respiratory failure,” said the study’s corresponding author, Dr. Hsiang-Wen Lin, RPh, MS, PhD, researcher of outcomes research and Associate Professor at the China Medical University’s College of Pharmacy. “Such profound economic burden warrants more aggressive effort to improve current diabetic care, to prevent patients from disease progression (e.g., respiratory failure) or hospitalization. Results from this study could help develop public health strategies to improve diabetes management and alleviate economic and social burdens of health care in our health system.” The full study, “Economic Burden of Diabetes Mellitus on Respiratory Failure Patients Requiring Mechanical Ventilation during Hospitalizations” is published in Value in Health Regional Issues, Volume 3.

Value in Health Regional Issues (ISSN 2212-1099) is a scientific journal that encourages and enhances the science of pharmacoeconomic/health economic and health outcomes research and its use in health care decisions. The journal is published up to three times a year with one issue focusing on the Asia region, one issue focusing on the Latin America region, and one issue focusing on the Central & Eastern Europe, Western Asia and Africa regions.

The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) is a nonprofit, international, educational and scientific organization that strives to increase the efficiency, effectiveness, and fairness of health care resource use to improve health.

Follow Value in Health Regional Issues on Twitter: @ISPORJournals

Related Stories

Value in Health Regional Issues Expands Editorial Scope and Reveals Plans to Transition to Gold Open Access Model

Jan 23, 2024

Value in Health Regional Issues, an official journal of ISPOR—The Professional Society for Health Economics and Outcomes Research, announced the expansion of its editorial scope and its plan to transition to a gold open access journal.

Empowering Change: Transforming Health Systems in Low- and Middle-Income Countries

Jan 22, 2024

ISPOR announced the publication of a special themed section of research papers in Value in Health Regional Issues that highlight innovative approaches to improving health outcomes in low- and middle-income countries through partnerships between health economics researchers and policy makers.

ISPOR’s Value in Health Regional Issues Receives Its First Impact Factor Score

Aug 7, 2023

Value in Health Regional Issues, the regionally focused journal of ISPOR, received its first-ever impact factor score this year. Value in Health, one of the top-ranked journals in the HEOR field, maintained its high ranking on the prestigious list of scholarly journals.
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on Update my browser now